These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6292563)

  • 1. Accessory cell function in tumor-bearing mice and effects of Corynebacterium parvum.
    Okuda S; Taniguchi K; Kubo C; Nomoto K
    J Natl Cancer Inst; 1982 Dec; 69(6):1293-7. PubMed ID: 6292563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
    Dimitrov NV; Denny TN; Weisman MF; Cameron DG
    J Natl Cancer Inst; 1979 Aug; 63(2):423-6. PubMed ID: 379400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant effects of Blastomyces dermatitidis against EL 4 lymphoma in C57BL/6J mice.
    McDaniel LS; Cozad GC
    J Natl Cancer Inst; 1982 Dec; 69(6):1337-42. PubMed ID: 6958909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
    Watson SR; Sljivić VS
    Clin Exp Immunol; 1976 Jan; 23(1):149-53. PubMed ID: 770033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the enhancement of the antibody response in vitro by C. parvum.
    Slijivíc VS; Brown CA; Watson SR
    Dev Biol Stand; 1977 Apr 13-15; 38():147-52. PubMed ID: 608502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
    Lee KC; Berry D
    J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effects of Corynebacterium parvum on primary and secondary antibody responses in mice.
    Ansell JD; Trail KN; McDougall CM; Inchley CJ
    J Reticuloendothel Soc; 1983 Oct; 34(4):311-21. PubMed ID: 6620257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.
    Matthews TJ; Weinhold KJ; Langlois AJ; Bolognesi DP
    J Natl Cancer Inst; 1985 Oct; 75(4):703-8. PubMed ID: 3862902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.
    Kirchner H; Holden HT; Herberman
    J Immunol; 1975 Nov; 115(5):1212-6. PubMed ID: 1176773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 16. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
    Scott MT; Warner SL
    Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
    Miyata H; Himeno K; Miake S; Nomoto K
    Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of macrophage function by 2-chloroadenosine.
    Ohtani A; Kumazawa Y; Fujisawa H; Nishimura C
    J Reticuloendothel Soc; 1982 Sep; 32(3):189-200. PubMed ID: 7153986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.